P14 expression, with or without simultaneous p53 expression, was significantly associated with shorter survival in patients treated with adjuvant chemotherapy, indicating that p14 might be involved in tumor response to chemotherapy [82]. This evidence concerns the gene CDKN2A and neoplasm.